OBJECTIVE: To compare synovial tissue cytokine mRNA expression between patients with juvenile rheumatoid arthritis (JRA) and a heterogeneous group of non-autoimmune arthropathies (controls) with respect to type 1/type 2 balance. METHODS: Thirty-five JRA (average 9.1 years' disease duration) and 13 control synovial tissues were studied. As a measure of the type 1/type 2 cytokine balance in a subset of the JRA and control tissues, interferon-gamma (IFN-gamma) and interleukin 4 (IL-4) mRNA levels were measured by competitive fragment reverse transcription-polymerase chain reaction. To quantitate additional cytokines relevant to this balance, multiprobe ribonuclease protection assays were employed measuring IL-5, IL-10, IL-13, IL-15, IL-18, and IL-12 (p35 and p40 subunits). Immunohistochemistry was performed on JRA tissues using antibodies specific for IL-15 and IL-18. RESULTS: A higher IFN-gamma:IL-4 ratio (p = 0.034) was found in JRA tissues compared to controls. JRA tissues also displayed higher mRNA levels of IL-12p35 (p = 0.021), IL-15 (p = 0.002), and IL-18 (p = 0.017), but not IL-4 and IL-10. IFN-gamma expression in JRA, but not controls, correlated strongly with IL-12p35 (r = 0.63) and IL-12p40 (r = 0.73) levels. A subset of IL-15+ and IL-18+ cells was detected in JRA synovial tissues, largely within perivascular aggregates. CONCLUSION: JRA synovial tissue cytokine expression patterns indicate a type 1 bias, even in the later stages of disease. The strong correlation between IFN-gamma and IL-12 in JRA suggests a prominent role for IL-12 in promoting the type I bias, while IL-15 and IL-18 may also indirectly increase IFN-gamma expression and further bias the immune response.
OBJECTIVE: To compare synovial tissue cytokine mRNA expression between patients with juvenile rheumatoid arthritis (JRA) and a heterogeneous group of non-autoimmune arthropathies (controls) with respect to type 1/type 2 balance. METHODS: Thirty-five JRA (average 9.1 years' disease duration) and 13 control synovial tissues were studied. As a measure of the type 1/type 2 cytokine balance in a subset of the JRA and control tissues, interferon-gamma (IFN-gamma) and interleukin 4 (IL-4) mRNA levels were measured by competitive fragment reverse transcription-polymerase chain reaction. To quantitate additional cytokines relevant to this balance, multiprobe ribonuclease protection assays were employed measuring IL-5, IL-10, IL-13, IL-15, IL-18, and IL-12 (p35 and p40 subunits). Immunohistochemistry was performed on JRA tissues using antibodies specific for IL-15 and IL-18. RESULTS: A higher IFN-gamma:IL-4 ratio (p = 0.034) was found in JRA tissues compared to controls. JRA tissues also displayed higher mRNA levels of IL-12p35 (p = 0.021), IL-15 (p = 0.002), and IL-18 (p = 0.017), but not IL-4 and IL-10. IFN-gamma expression in JRA, but not controls, correlated strongly with IL-12p35 (r = 0.63) and IL-12p40 (r = 0.73) levels. A subset of IL-15+ and IL-18+ cells was detected in JRA synovial tissues, largely within perivascular aggregates. CONCLUSION: JRA synovial tissue cytokine expression patterns indicate a type 1 bias, even in the later stages of disease. The strong correlation between IFN-gamma and IL-12 in JRA suggests a prominent role for IL-12 in promoting the type I bias, while IL-15 and IL-18 may also indirectly increase IFN-gamma expression and further bias the immune response.
Authors: Ligong Chen; Jarad M Schiffer; Shannon Dalton; Carol L Sabourin; Nancy A Niemuth; Brian D Plikaytis; Conrad P Quinn Journal: Clin Vaccine Immunol Date: 2014-09-03
Authors: Sudha Visvanathan; Carrie Wagner; Joseph C Marini; Daniel J Lovell; Alberto Martini; Ross Petty; Ruben Cuttica; Patricia Woo; Graciela Espada; Marco Gattorno; Maria T Apaz; Eileen Baildam; Anders Fasth; Valeria Gerloni; Pekka Lahdenne; Pierre Quartier; Rotraud Saurenmann; Suzanne Travers; Alan Mendelsohn; Stephen Xu; Edward H Giannini; Nicolino Ruperto Journal: Pediatr Rheumatol Online J Date: 2010-09-07 Impact factor: 3.054
Authors: Jeffrey H Ruth; Christy C Park; M Asif Amin; Charles Lesch; Hubert Marotte; Shiva Shahrara; Alisa E Koch Journal: Arthritis Res Ther Date: 2010-06-16 Impact factor: 5.156
Authors: Marija Jelusić; Ivan Kresimir Lukić; Lana Tambić-Bukovac; Klara Dubravcić; Ivan Malcić; Igor Rudan; Drago Batinić Journal: Clin Rheumatol Date: 2006-11-25 Impact factor: 2.980
Authors: Susan D Thompson; Miranda C Marion; Marc Sudman; Mary Ryan; Monica Tsoras; Timothy D Howard; Michael G Barnes; Paula S Ramos; Wendy Thomson; Anne Hinks; Johannes-Peter Haas; Sampath Prahalad; John F Bohnsack; Carol A Wise; Marilynn Punaro; Carlos D Rosé; Nicholas M Pajewski; Michael Spigarelli; Mehdi Keddache; Michael Wagner; Carl D Langefeld; David N Glass Journal: Arthritis Rheum Date: 2012-08